News 2023-06-23
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Dear valued customers and partners,
We would like to extend our gratitude for your continuous support towards Porton Pharma Solutions Ltd. In order to further enhance the company's brand recognition, adapt to our global development strategy, improve communication efficiency, and protect each other's information security, we have decided to change our email domain name from porton.cn to portonpharma.com.
We will be discontinuing the use of the old email addresses and will automatically forward all emails sent to the old addresses to the new address in the coming weeks or so. To avoid any unnecessary delays, we strongly recommend that you start using the new email address to contact us starting from August 13, 2023.
![]()
We look forward to maintaining closer contact with you and achieving greater business success together. If you have any questions or need further assistance, please feel free to contact us at any time.
We apologize for any inconvenience caused by this change and appreciate your understanding!
Chinese website: www.porton.cn
English website: www. portonpharma.com
Others
More
News 2026-09-17
Porton Congratulates Partner Acepodia on FDA and NMPA IND Approvals for ACE723, a Dual-Payload ADC
This project demonstrates Porton's process-development and scale-up capabilities for complex conjugates and adds to its experience supporting innovative biopharma companies worldwide.

News 2026-09-15
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
This successful recertification highlights the standardized operation of the site's management systems, the rigor of its on-site management, and the robustness of its risk control mechanisms, further validating the continued effectiveness of the dual systems.